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Background: Giant placental chorioangiomas have been associated with a number of severe fetal complications
and high perinatal mortality.
Case presentation: We report a case of giant chorioangioma with fetal hydrops, additionally complicated by
severe anemia, mild cardiomegaly with hyperdinamic heart circulation and maternal mirror syndrome. Intrauterine
blood transfusion and amniodrainage was performed at 29 weeks. Worsening of the fetal and maternal condition
prompted us to proceed with delivery at 29 + 5 weeks. The newborn died 3 hours later due to pulmonary
hypoplasia and hemodynamic failure. Maternal course was favourable, mirror syndrome resolved in the second day
and the patient was discharged four days following delivery.
Conclusions: In the case described here, fetal condition got worse despite of the anemia correction and
amniodrainage. Our outcome raises the issue whether additional intrauterine clinical intervention, as intersticial
laser, should have been performed to stop further deterioration of the fetal condition when progressive severe
hydrops develops.
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Chorioangiomas are benign placenta tumors histologi-
cally corresponding either to hamartomas derived from
primitive chorionic mesenchyma or placental hemangi-
omas arising from chorionic plate [1]. Large or giant
chorioangiomas, defined as measuring more than 4–5 cm
in diameter, have an estimated prevalence varying from
one in 9000 to one in 50 000 pregnancies [1], and have
been associated with a number of fetal complications in-
cluding anemia, polyhydramnios, hyperdynamic circula-
tion and cardiomegaly, hydrops, and growth restriction
[2-6]. In view of these complications and the associated* Correspondence: guillermo.antinolo.sspa@juntadeandalucia.es
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distribution, and reproduction in any mediumhigh perinatal death rate (30–40%), a number of thera-
peutic interventions have been attempted with limited
success in most cases [5,7,8].
Here we report a case of giant chorioangioma, fetal
hydrops, additionally complicated by severe anemia,
mild cardiomegaly with hyperdinamic heart circulation
and maternal mirror syndrome.Case presentation
A 34-year-old woman, gravida 1, was referred to our
Department at 29 weeks´ gestation because of placental
chorioangioma, severe hydrops fetalis, suspected fetal
anemia and maternal mirror syndrome (Ballantine’s syn-
drome), previously not detected. Ultrasound examin-
ation confirmed fetal hydrops with hydrothorax and
ascitis, fetal anemia (middle cerebral artery peak systolic
velocity: 74.3 cm/sg with an estimated haemoglobin of
7.14 g/dl), polyhydramnios (maximum pocket 14),tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 2 Macroscopic view of giant placental choriangioma.
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(cardiac area more than 1/3 of thoracic area) with hyper-
dinamic heart circulation. In addition, ultrasound exam-
ination showed the presence of a heterogenous
hypoechoic area of 70x56 mm, with color Doppler show-
ing a specific blood supply, both consistent with diagnosis
of chorioangioma (Figure 1). Maternal examination was
consistent with mirror syndrome (edema, oliguria, anemia,
elevated liver enzymes, hypoproteinemia and hypokal-
emia). Blood pressure was normal. At 29+ 1 weeks, treat-
ment with 12 mg betamethasone injections (two doses
separated in 24hours) was given; intrauterine transfusion
(IUT) of 80 ml of packed red blood cell suspension with a
70% hematocrit was performed, and followed by amnio-
drainage. Initial fetal hematocrit was 7 g/dL and final one
was 12 g/dL. 1800 ml of amniotic fluid were drained,
reducing maximum pocket to 5 cm. Within the next
hour preterm labor developed, therapy with atosiban
and nifedipine was initiated and the contractions sub-
sided. At 29+ 5 weeks’ gestation, fetal ultrasound
showed worsening of the fetal hydrothorax as well as
pulsatility index of the umbilical artery over 95th centile.
In addition, worsening of the maternal mirror syndrome
(pleural effusion and increasing levels of liver enzymes)
was noted. Worsening of the fetal and maternal condi-
tion prompted us to proceed with delivery at
29+ 5 weeks’. A thoracocentesis to optimise the neonatal
resuscitation was performed in the operating room, and
was immediately followed by the caesarean section. The
newborn weighed 2503 g and apgar score was 1 and 4
at 1 and 5 min. The newborn died 3 hours later due to
pulmonary hypoplasia and hemodynamic failure. Mater-
nal course was favourable, mirror syndrome resolved in
the second day and the patient was discharged four
days following delivery. Histological analysis confirmed
the diagnosis of placental chorioangioma (Figure 2).
Microscopic examination showed that the chorioangiomaFigure 1 Color Doppler of giant placental choriangioma.was composed of predominantly capillary vascular areas
in the fibroid matrix.
Discussion
Around 50% of large chorioangiomas cases develop fetal
and maternal complications that required either elective
delivery or intervention for tumor-related effects [9].
Chorioangiomas may act as peripheral arteriovenous
shunts, leading to increased cardiac output, cardiomeg-
aly and finally heart failure and hydrops, additionally
complicated by fetal anemia in some cases [2-6]. When
complications appear late in pregnancy, the best option
is delivery. However, complications may appear earlier
and delivery may be a problem due to fetal prematurity.
Thus, different interventions have been proposed to pre-
vent fetal loss related to large fetal chorioangioma com-
plications. Amniodrainage for alleviating polyhydramnios
[3,5,7] and intrauterine transfusions in the presence of
fetal anemia are two of the most common therapeutic
procedures [7,10-12], although results are favorable, the
problem that causes increased peripheral flow through
the chorioangioma, it is not solved with amniodrainage
or fetal transfusion. For that reason, other approaches
have been used to stop vascular supply to the tumor and
consequent heart failure. In addition to amniodrainage
or fetal transfusion, different techniques have been used
as injection of absolute alcohol [13-15], endoscopic laser
coagulation [16,17], and interstitial laser therapy [4,7],
endoscopic suture with bipolar electrosurgery [18], and
microcoil and embucrilate embolization, the last two
procedures without survivors [9,13,18]. Table 1
summarize a literature review of therapy (excluding
amniodrainage alone) and the presence/absence of
hydrops as well as other complications in chorioangioma
cases. When analysing the overall results of intraturine
Table 1 Literature review of therapy (excluding amniodrainage alone), presence/absence of hydrops, and other
complications in giant chorioangioma cases
Reference Case # Greatest tumor
diameter (mm)
Hydrops Other complications Intrauterine therapy Delivery
(weeks)
Pregnancy
outcome
This report 1 78 Yes Polyhidramnios,
hydrothorax, mild
cardiomegaly, fetal
anemia, mirror
syndrome
Intrauterine transfusion +
amniodrainage (29 weeks)
29+6 Neonatal death
Zanardini (2010) 2 42 No Polyhydramnios and
cardiomegaly
Fetoscopic laser (24+3 weeks) 36+3 Live birth
Zanardini (2010) 3 45 No Moderate cardiomegaly Interstitial laser (25+4
and 26+4 weeks)
32+3 Live birth
Zanardini (2010) 4 35 No Mild cardiomegaly
and fetal anemia
Interstitial laser (32+3 weeks) 39+1 Live birth
Zanardini (2010) 5 54 No Mild cardiomegaly
and fetal anemia
Amniodrainage (28+6 weeks) 37+3 Live birth
Intrauterine blood
transfusion (29 weeks)
Interstitial laser (29 and
30+4 weeks)
Sisvali (2009) 1 70 Yes Fetal anemia Intrauterine blood
transfusion at 26
27 Live birth
Mendez-Figueroa
(2009)
1 43 Yes Fetal anemia Amniodrainage 26 Fetal demise
Intrauterine blood transfusion
Fetoscopy: bipolar and
laser coagulation
Bermúdez (2007) 1 61 Yes Fetal anemia Intrauterine blood transfusion. 27 Fetal demise
Fetoscopic laser coagulation
Amniodrainage
Deren (2007) 1 83 Yes Fetal anemia Intrauterine blood transfusion. 28 Live birth
Alcohol injection into the
tumor (25 and 26 weeks)
Quarello (2005) 1 44 Yes No Fetoscopic laser coagulation
Amniodrainage
39 Live birth
Escribano D
(2005)
1 81 No Fetal anemia Intrauterine blood transfusion
(25 weeks, 60 ml)
39 Live birth
Lau (2005) 1 90 Yes Polyhydramnios Ultrasound guided transcutaneous
embolisation with enbucrilate
(24+2 weeks)
26 Neonatal death
Lau (2003) 1 74 No Fetal anemia Intrauterine blood transfusion
(24th weeks, 50 ml)
29 +6 Neonatal death
Ultrasound-guided transcutaneous
embolisation with microcoil
(24+2th weeks, 8 pieces)
Intrauterine blood transfusion
(25th weeks, 60 ml)
Ultrasound-guided transcutaneous
embolisation with microcoil
(25th weeks, 9 pieces)
Intrauterine blood transfusion
(27th 28th 29th weeks
Sepúlveda (2003) 1 75 Yes Severe polyhydramnios
and cardiac faillure
Alcohol ablation (26 weeks) 26 Fetal demise
(26 weeks)
Nicolini (1999) 1 60 No Polyhydramnios Amniodrainage N/A Live birth
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Table 1 Literature review of therapy (excluding amniodrainage alone), presence/absence of hydrops, and other
complications in giant chorioangioma cases (Continued)
Alcohol ablation (27 weeks)
Nicolini (1999) 2 50 No Polyhidramnios Alcohol ablation
(24 and 25 weeks)
N/A Live birth
Haak (1999) 1 68 No Fetal anemia
Polyhidramnios
Intrauterine blood transfusion
(30 weeks, 100 ml)
32 Live birth
Quintero (1996) 1 85 Yes Fetal anemia Fetoscopy and devascularisation
by suture ligation and bipolar
cautery (24th weeks)
24+3 Fetal demise
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without fetal hydrops is 10%, while mortality in cases
with fetal hydrops raises to 67%. In fact, all successful
intersticial laser procedures [4,7] were performed to pre-
vent the development of fetal hydrops.
Mirror syndrome (Ballantyne’s syndrome) is usually
defined as maternal edema associated to fetal hydrops
[19]. Different fetal conditions have been related to mir-
ror syndrome, although pathogenesis and pathofisiology
of Ballantyne’s syndrome is currently unknown [19].
Mirror syndrome associated to large placental chorioan-
giomas has been described only a few times [20-23] and
maternal edema has been always present, as was in our
case. In addition, other clinical markers also been
reported as oliguria, anemia, elevated liver enzymes,
hypoproteinemia and hypokalemia were also present in
our patient. Additional clinical signs and symptoms
described in Mirror syndrome related to large chorioan-
giomas such as elevated blood pressure, proteinuria, ele-
vated uric acid and creatinine, headache and visual
disturbances, and low platelets were absent in our case,
which made easier differential diagnosis with preeclamp-
sia. As described elsewhere [19] mirror syndrome disap-
pears shortly after fetal hydrops successful treatment,
pregnancy termination or delivery, as in the patient pre-
sented here.Conclusions
In the case described here, which presented with fetal
anemia and severe hydrops, additionally complicated by
maternal mirror syndrome, intrauterine transfusion and
amniodrainage were performed. However, fetal condition
got worse despite of the anemia correction. Finally, an
emergency cesarean section, after thoracocentesis to op-
timise the neonatal resuscitation, was performed due to
worsening of maternal and fetal condition and to pre-
vent fetal demise. Current data and experience from
clinical practice are still scanty to support the effective-
ness of intrauterine therapy procedures in chorioan-
gioma complicated cases, specially in cases with fetal
hydrops, which led us to attempt a more conservative
approach. However, our outcome raises the issuewhether additional intrauterine clinical intervention, as
intersticial laser, should have been performed to stop
further deterioration of the fetal condition when pro-
gressive severe hydrops develops.Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images, as it is our usual publication policy according to
our Internal Review Board instructions.
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